Actuate Therapeutics Statistics
NASDAQ: ACTUHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.2253+0.0115 (+5.38%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Actuate Therapeutics by the numbers
Actuate Therapeutics has a market capitalization of $13.6 million based on 60.38M shares outstanding. With trailing EPS of $-0.76, Actuate Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 60.0% below its 50-day average and 87.4% below its 200-day average.
Average daily trading volume is 807.24K shares, or about $181,872 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ACTU valuation vs. peer median
| Metric | ACTU | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.60M | $13.01M | +5% |
| Avg. volume | 807.24K | 183.84K | +339% |
Peer median across 8 companies: BYSI, CTXR, TVRD, BOLT, NEUP, MCRB, ALLR, NCEL.
Valuation
- Market cap
- $13.60M
- EPS (TTM)
- $-0.76
- Shares outstanding
- 60.38M
Price and trading
- Previous close
- 0.2138
- Open
- 0.20
- Day range
- 0.20 – 0.2475
- 52-week range
- 0.174 – 7.90
- 52-week change
- -96.43%
- 50-day moving average
- 0.5639
- Beta
- —
- Volume
- 629.80K
- Average volume
- 807.24K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 13.60M
- Forward Pe
- -0.58
- Eps
- -0.76
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.90
- Week52 Low
- 0.17
- Avg Volume
- 807.24K
- Shares Outstanding
- 60.38M
- Ma50
- 0.56
- Ma200
- 1.79
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -97.15%
- Pct From52w Low
- 29.48%